Clinical Study of Dexpramipexole in Amyotrophic Lateral Sclerosis (ALS)
A randomized, double-blind, placebo-controlled, multi-center study of the safety and efficacy of Dexpramipexole in subjects with amyotrophic lateral sclerosis. - EMPOWER A randomized, double-blind, placebo-controlled, multi-center study of the safety and efficacy of Dex ...